Carregant...
Designing Chimeric Antigen Receptors to Effectively and Safely Target Tumors
The adoptive transfer of T cells engineered to express artificial chimeric antigen receptors (CARs) that target a tumor cell surface molecule has emerged as an exciting new approach for cancer immunotherapy. Clinical trials in patients with advanced B cell malignancies treated with CD19-specific CAR...
Guardat en:
| Publicat a: | Curr Opin Immunol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4397136/ https://ncbi.nlm.nih.gov/pubmed/25621840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2015.01.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|